Global Oral Solid Dosage Contract Manufacturing Market Size & Outlook

The global oral solid dosage contract manufacturing market size was estimated at USD 38,638.6 million in 2024 and is projected to reach USD 54,718.2 million by 2030, growing at a CAGR of 6% from 2025 to 2030.
Revenue, 2024 (US$M)
$38,638.6
Forecast, 2030 (US$M)
$54,718.2
CAGR, 2025 - 2030
6%
Report Coverage
Worldwide

Global oral solid dosage contract manufacturing market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Global oral solid dosage contract manufacturing market highlights

  • The global oral solid dosage contract manufacturing market generated a revenue of USD 38,638.6 million in 2024 and is expected to reach USD 54,718.2 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 6% by 2030.
  • In terms of segment, tablets accounted for a revenue of USD 12,651.9 million in 2024.
  • Capsules is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, Asia Pacific was the largest revenue generating market in 2024.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.

Global data book summary

Market revenue in 2024USD 38,638.6 million
Market revenue in 2030USD 54,718.2 million
Growth rate6% (CAGR from 2025 to 2030)
Largest segmentTablets
Fastest growing segmentCapsules
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTablets, Capsules, Powders, Granules

Other key industry trends

  • In terms of revenue, the North America accounted for 33.1% of the global oral solid dosage contract manufacturing market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, India is the fastest growing regional market and is projected to reach USD 5,750.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Oral Solid Dosage Contract Manufacturing Market Companies

Name Profile # Employees HQ Website
Novacyt SA View profile 222 13, Avenue Morane Saulnier, Velizy-Villacoublay, France, 78140 https://www.novacyt.com
Jubilant Pharmova View profile 10001+ Noida, Uttar Pradesh, India, Asia https://www.jubilantpharmova.com
CordenPharma View profile 5001-10000 Plankstadt, Baden-Wurttemberg, Germany, Europe http://cordenpharma.com
Piramal Pharma Solutions View profile 1001-5000 Riverview, Michigan, United States, North America http://www.piramalpharmasolutions.com/
Recipharm View profile 1001-5000 Jordbro, Stockholms Lan, Sweden, Europe http://www.recipharm.com
Siegfried Holding AG View profile 4180 Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 https://www.siegfried.ch
Catalent Inc View profile 17219 14 Schoolhouse Road, Somerset, NJ, United States, 08873 https://www.catalent.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com

Global oral solid dosage contract manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.


Tablets was the largest segment with a revenue share of 32.74% in 2024. Horizon Databook has segmented the Global oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Oral Solid Dosage Contract Manufacturing Product Outlook (Revenue, USD Million, 2018-2030)
    • Powders
    • Granules
    • Others
    • Tablets
    • Capsules
  • Global Oral Solid Dosage Contract Manufacturing Mechanism Outlook (Revenue, USD Million, 2018-2030)
    • Controlled Release
    • Immediate Release
    • Delayed Release
  • Global Oral Solid Dosage Contract Manufacturing End User Outlook (Revenue, USD Million, 2018-2030)
    • Medium & Small Size Companies
    • Large Size Companies
    • Others

Reasons to subscribe to Global oral solid dosage contract manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global oral solid dosage contract manufacturing market databook

  • Our clientele includes a mix of oral solid dosage contract manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global oral solid dosage contract manufacturing market , including forecasts for subscribers. This global databook contains high-level insights into Global oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global oral solid dosage contract manufacturing market size, by regions, 2018-2030 (US$M)

Top 10 countries: Oral solid dosage contract manufacturing market size, 2024 (US$M)

Global oral solid dosage contract manufacturing market share, by mechanism, 2024 & 2030 (%, US$M)

Oral solid dosage contract manufacturing market: Opportunity assessment by country

Global oral solid dosage contract manufacturing market, by region, 2024 (US$M)

Global oral solid dosage contract manufacturing market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online